Isocard

Isosorbide dinitrate, the active ingredient in Isocard, is a nitrate presented as a sublingual formulation for sublingual use. It is employed to relieve episodes of angina pectoris by dilating coronary vessels and lowering myocardial oxygen consumption in adult patients.

GNH USA supplies Isocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides reliable logistics for global healthcare providers. Products are shipped with appropriate temperature control and documentation to meet regulatory requirements of each destination market.

Isocard (isosorbide dinitrate) is a nitrate that acts on the coronary vasculature to alleviate ischemic chest pain.

Angina pectoris: provides rapid relief of acute episodes by vasodilation and decreasing cardiac workload. Chronic stable angina: reduces the frequency of attacks when used regularly as prophylaxis. Exercise‑induced angina: improves exercise tolerance by enhancing myocardial oxygen supply.

Isocard may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Headache - Flushing - Dizziness - Low blood pressure (hypotension)

Serious or Rare Side Effects: - Severe hypotension - Syncope - Allergic reaction (rash, swelling, or anaphylaxis)

Before prescribing Isocard, clinicians should consider several safety aspects.

Avoid use in patients with severe hypotension: monitor blood pressure before administration. Do not combine with phosphodiesterase‑5 inhibitors: risk of profound vasodilation. Use caution in patients with recent myocardial infarction: may increase cardiac workload. Adjust dose in renal impairment: excretion may be reduced. Pregnancy and breastfeeding: safety not established; use only if benefit outweighs risk. Store at ambient temperature below 25°C: keep in original container, protect from moisture and light.

Isocard can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Concomitant use with other nitrates (e.g., nitroglycerin) may cause severe hypotension. - Use with phosphodiesterase‑5 inhibitors (sildenafil, tadalafil) can lead to dangerous blood pressure drops. - Concurrent use with potent vasodilators (hydralazine) increases risk of additive hypotension.

Moderate Interactions (Monitor Closely): - Loop diuretics may enhance hypotensive effect; monitor fluid status. - Antihypertensive agents (beta‑blockers, ACE inhibitors) may require dose adjustment.